ABOUT IDBS

  

IDBS helps research and development (R&D) teams and scientists, in biologics development and drug discovery and development, around the world make discoveries that have the potential to transform the lives of populations worldwide. Our diverse customer list includes 22 of the top 25 global pharmaceutical companies, and other R&D-driven organizations in biotechnology, agricultural sciences, chemicals, consumer goods, energy, food and beverage, and healthcare.

We want our technology and solutions to help leading organizations, and their people, solve some of the world’s biggest challenges. Our drive for simplicity and innovation ensures we lead the way and transform R&D worldwide. Our cloud-based solutions are designed to meet the challenges faced by organizations, and their scientists, in scientific data management and lab informatics. Using our expertise and experience we want to enable our customers around the world to get back to what they do best: science. We are always adding to the R&D driven global companies we support in a diverse range of industries, including pharmaceuticals, biotechnology, agricultural sciences, chemicals, consumer goods, energy, engineering, food and beverage, and healthcare.

WEBINARS

  • This webinar tackles the key COVID-19-related disruptions affecting manufacturing, data management and R&D in the lab, and how digital technology investments impact drug discovery and marketability.

  • IDBS are announcing the world’s first Biopharma Lifecycle Management (BPLM) system – a cloud-based platform that smooths the bumps of biopharmaceutical development – easing the curation of the data you need to accelerate time to market.

  • This presentation will explore tools that biopharma development organizations can use to prepare for digital transformation. We will discuss tools that help companies visualize complex processes in a simple diagram, tools for identifying waste and inefficiency in the process, and tools for visualizing the steps of complex processes.

  • Often, scientific R&D data is not replicable or re-useable, holding a company back. In addition to racking up costs, it highlights that there are important things that need to be transformed in R&D. Your data needs to be findable, accessible, interoperable and re-useable. And managed by a system that can scale with your business. That’s what software can help you achieve.

  • Streamlining processes, ensuring consistency and risk reduction are widely sought objectives in the analytical laboratory. As sample volumes increase against fixed resources, especially in the contract market, service providers often turn to software to enable their people to meet these goals. The most effective solutions recognize the importance of direct integration of instrumentation with software to establish closed-loop, compliance workflows.

  • In our on-demand webinar you can learn how you could emulate Bayer’s success, and how they are continuing to use E-WorkBook to improve lab practices, increase laboratory efficiency and build a laboratory environment suited for business needs both now and in the future.

VIDEOS

  • Since 1989 IDBS has supported innovation leaders in most industries like energy, agriculture, consumer goods, food and beverage and biopharmaceutical development with premium digital solutions for research and development. Accelerating discovery through streamlined workflows increased integration of instruments, processes and data and shorter reporting cycles for strategic insight.

  • This webinar tackles the key COVID-19-related disruptions affecting manufacturing, data management and R&D in the lab, and how digital technology investments impact drug discovery and marketability.

  • Managing bioprocess data is a complex challenge even if you run just a few experiments per month. With HTPD this can quickly scale up to hundreds of automated, parallelized experiments. Used effectively as part of a BioPharma Lifecycle Management strategy, the data generated from HTPD can accelerate development by supporting better decision making and reducing timelines. Introducing IDBS Polar HTPD. High-throughput data management is finally coming to high-throughput process development.

  • IDBS are announcing the world’s first Biopharma Lifecycle Management (BPLM) system – a cloud-based platform that smooths the bumps of biopharmaceutical development – easing the curation of the data you need to accelerate time to market.

  • This presentation will explore tools that biopharma development organizations can use to prepare for digital transformation. We will discuss tools that help companies visualize complex processes in a simple diagram, tools for identifying waste and inefficiency in the process, and tools for visualizing the steps of complex processes.

  • Often, scientific R&D data is not replicable or re-useable, holding a company back. In addition to racking up costs, it highlights that there are important things that need to be transformed in R&D. Your data needs to be findable, accessible, interoperable and re-useable. And managed by a system that can scale with your business. That’s what software can help you achieve.

  • Streamlining processes, ensuring consistency and risk reduction are widely sought objectives in the analytical laboratory. As sample volumes increase against fixed resources, especially in the contract market, service providers often turn to software to enable their people to meet these goals. The most effective solutions recognize the importance of direct integration of instrumentation with software to establish closed-loop, compliance workflows.

  • Adding streamlined workflows designed for biopharmaceutical development to your software toolbox is probably the easiest and fastest way to reduce time-to-market. Because tailored, best practice workflows will ensure more complete data capture with context – for faster strategic insight. By deploying the IDBS Bioprocess Solution with new workflows for antiviral therapeutics to record high-quality, contextualized data – at the moment it is acquired.

  • Process development doesn’t mean working harder. It doesn’t mean running faster. Or even automation and better equipment. It means “unfolding progression”. And that’s exactly what we do. We help leading CDMOs to improve their workflows, data quality and processes for faster and better results. We do it by offering superior R&D software, customized for biopharmaceutical development.

  • At IDBS we create cloud-based solutions designed to meet the challenges of scientific and R&D data management for organizations around the world.

  • E-WorkBook is a complete end-to-end, cloud-based, research and development platform that supports all your internal, external and hybrid data management and research needs.

  • In our on-demand webinar you can learn how you could emulate Bayer’s success, and how they are continuing to use E-WorkBook to improve lab practices, increase laboratory efficiency and build a laboratory environment suited for business needs both now and in the future.

  • Supporting your entire data ecosystem.

CONTACT INFORMATION

IDBS

285 Summer Street, Floor 5

Boston, MA 02210

UNITED STATES

Phone: (781) 852-0034

Contact: Jenn Thomas

FEATURED ARTICLES

  • Regardless of the industry an organization operates in, remaining compliant with ever-changing legislation is an important aspect of corporate operations. For businesses that focus on research and development (R&D) however, it’s essential. This is because of the frequently high-risk nature of the products being developed, and the potential for harm if there is an oversight during the testing process.

  • Are you clear on the role of metadata? Today there is an urgent need for the pharmaceutical industry to improve their data infrastructure to support metadata collection and curation so that data can be used and reused. This is because data don’t have much meaning without their accompanying metadata. Metadata comes with data; it gives it context. Simply put, metadata are bit of information permanently linked to raw data and will guarantee it has context.

  • The diverse nature of the individual steps in a given bioanalytical workflow requires a high level of accountability and traceability. While advances in detection techniques and instrumentation have vastly improved sample throughput, there is room for improvement when it comes to the myriad processes that drive sample analysis. This combination of controlled, compliant workflow execution and dramatically streamlined data acquisition is the next phase of innovation within bioanalysis.

  • To suit the various needs of sub-units within a big R&D department, users may combine different digital informatics systems. However, this is a mistake as the different systems often cannot communicate with each other, which creates unnecessary bottlenecks. This white paper starts by discussing the disjointed workflow arising from trying to integrate different digital informatics systems, followed by the consolidated  approach where all systems from one vendor are integrated into one suite.

  • The bottleneck just shifted from running as many experiments as possible to understanding them. Only now are companies starting to realize that even the current generation of modern lab informatics is unable to truly harness the full potential of high-throughput. Simply put, high-throughput process development requires high-throughput data management.